Pfizer opens $200m R&D site in St Louis

pharmafile | April 21, 2009 | News story | Research and Development |  Pfizer, US 

Related Content

ESTEVE CDMO commences $15.5m expansion of US facility

ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical …

Sharp invests $100m in US and EU manufacturing and packaging facilities

Sharp Services, a pharmaceutical packaging and sterile manufacturing specialist, has announced investments totalling $100m across …

clinical_trials_2

Moderna doses first US patient in phase 1 trial of mRNA-4106 for solid tumours

The START Center for Cancer Research has dosed the first US participant in Moderna’s phase …

The Gateway to Local Adoption Series

Latest content